| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.09. | Labcorp Completes Acquisition of BioReference Health Assets | ||
| 15.09. | Lonza Appoints Jason Berndt as Head of Group Operations | ||
| 15.09. | Corstasis Therapeutics' Enbumyst Gains FDA Approval | ||
| 15.09. | Abzena Introduces New GS Knockout Platforms | ||
| 15.09. | Avid Bioservices Appoints Kenneth Bilenberg as CEO | ||
| 12.09. | Alkermes Names Joshua Reed Chief Financial Officer | ||
| 12.09. | Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial | ||
| 12.09. | Medincell Appoints Three New Members to Board of Directors | ||
| 11.09. | Bausch Health Companies Acquires Durect Corporation | ||
| 11.09. | CPHI Frankfurt Returns to Germany October 28-30 | ||
| 11.09. | Charles River Collaborates to Advance Novel Oncology Research & Development | ||
| 11.09. | Corstasis Therapeutics Appoints Amin Medjamia as VP of Medical Affairs | ||
| 11.09. | Takeda Appoints Rhonda Pacheco as President of U.S. Business Unit | ||
| 11.09. | Matica Bio, Cirsium Biosciences Enter AAV Manufacturing Pact | ||
| 10.09. | AGC Biologics Seattle Facility Achieves Regulatory and Operational Milestones | ||
| 10.09. | Novo Nordisk Restructures, Reduces Workforce by 11% | ||
| 10.09. | BioIVT Announces New Office and Lab in Woodbury, NY | ||
| 10.09. | Wheeler Bio, Pharmefex Consulting Enter Partnership | ||
| 10.09. | Symeres Acquires DGr Pharma | ||
| 10.09. | Avanzanite Appoints Mark Bechter as SVP, Medical Affairs | ||
| 09.09. | Medable Launches Agent Studio | ||
| 09.09. | Abselion Launches AAVX and AAV9 Quantification Kits | ||
| 09.09. | Parexel Establishes New Global HQ in Raleigh, NC | ||
| 09.09. | Circle Pharma Partners with Eli Lilly to Boost AI-Driven Drug Discovery | ||
| 09.09. | Ethris & Evonik Join Forces to Advance Targeted mRNA Vaccines and Therapies |